Alzheimer’s disease (AD) has complex underlying mechanism associated with progressive decline in multiple aspects of brain functions. This work aims to characterize cerebral metabolic alteration in presymptomatic AD in terms of glucose uptake and β-hydroxybutyrate (βHB) concentration in hippocampus (HC) and entorhinal cortex (EC) of rat model of AD using MR imaging and spectroscopic techniques. Glucose uptake was significantly reduced in HC and trending toward decrease in EC with signs of elevated HC βHB concentration in AD transgenic rat when compared to metabolic markers in healthy subjects, demonstrating that metabolic alteration precedes onset of AD cognitive symptoms.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords